Joris Wilms
Chief Operating Officer, Y-mAbs Therapeutics, Inc.
Companies
- Y-mAbs Therapeutics, Inc.Chief operating officer Sep 20, 2018 to now1
- Y-mAbs Therapeutics, Inc.SVP & CCO Dec 16, 2020 to Dec 16, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Y-mAbs Therapeutics, Inc.0 shares3Sep 16, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2025Returned to company 39,301 shares of Y-mAbs Therapeutics, Inc.3
- Sep 16, 2025U 12,799 shares at $8.60 of Y-mAbs Therapeutics, Inc.3
- Jan 17, 2025Granted 21,500 shares of Y-mAbs Therapeutics, Inc.4
- Aug 26, 2024Sold 5,000 shares at $14.69 of Y-mAbs Therapeutics, Inc.5
- Jan 18, 2024Granted 17,800 shares of Y-mAbs Therapeutics, Inc.6
- Jan 17, 2023Granted 17,800 shares of Y-mAbs Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARY-mAbs Therapeutics, Inc., SVP & CCO
- 3
- 4SEC EDGARForm 4 filed Jan 22, 2025
- 5SEC EDGARForm 4 filed Aug 27, 2024
- 6SEC EDGARForm 4 filed Jan 22, 2024
- 7SEC EDGARForm 4 filed Jan 19, 2023